Put Options

21 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$41.99 - $62.38 $125,970 - $187,140
3,000 New
3,000 $0
Q2 2023

Jul 18, 2023

BUY
$36.13 - $49.49 $3,613 - $4,949
100 New
100 $0
Q4 2022

Feb 07, 2023

BUY
$41.27 - $98.62 $28,889 - $69,034
700 Added 70.0%
1,700 $10,000
Q2 2022

Aug 04, 2022

SELL
$39.16 - $88.71 $140,976 - $319,356
-3,600 Reduced 78.26%
1,000 $1,000
Q4 2021

Jan 18, 2022

SELL
$132.01 - $190.29 $2.69 Million - $3.88 Million
-20,400 Reduced 81.6%
4,600 $22,000
Q3 2021

Oct 26, 2021

BUY
$132.13 - $177.45 $3.11 Million - $4.17 Million
23,500 Added 1566.67%
25,000 $67,000
Q2 2021

Jul 19, 2021

SELL
$144.0 - $179.73 $950,400 - $1.19 Million
-6,600 Reduced 81.48%
1,500 $0
Q4 2020

Jan 21, 2021

SELL
$162.05 - $240.27 $81,025 - $120,135
-500 Reduced 5.81%
8,100 $1,000
Q3 2020

Oct 27, 2020

SELL
$113.26 - $167.27 $249,172 - $367,994
-2,200 Reduced 20.37%
8,600 $49,000
Q2 2020

Jul 22, 2020

SELL
$72.01 - $120.39 $403,256 - $674,184
-5,600 Reduced 34.15%
10,800 $74,000
Q1 2020

May 07, 2020

BUY
$69.78 - $116.21 $272,142 - $453,219
3,900 Added 31.2%
16,400 $215,000
Q4 2019

Feb 06, 2020

BUY
$70.76 - $128.86 $375,028 - $682,958
5,300 Added 73.61%
12,500 $124,000
Q3 2019

Oct 28, 2019

SELL
$77.91 - $109.6 $545,370 - $767,200
-7,000 Reduced 49.3%
7,200 $271,000
Q2 2019

Aug 09, 2019

BUY
$59.49 - $104.71 $285,552 - $502,607
4,800 Added 51.06%
14,200 $134,000
Q1 2019

May 10, 2019

BUY
$43.65 - $78.95 $209,520 - $378,960
4,800 Added 104.35%
9,400 $15,000
Q4 2018

Feb 05, 2019

SELL
$32.0 - $47.43 $1.13 Million - $1.67 Million
-35,300 Reduced 88.47%
4,600 $1,000
Q3 2018

Nov 07, 2018

BUY
$47.1 - $62.7 $1.31 Million - $1.75 Million
27,900 Added 232.5%
39,900 $515,000
Q2 2018

Aug 10, 2018

BUY
$26.05 - $52.4 $307,390 - $618,320
11,800 Added 5900.0%
12,000 $15,000
Q1 2018

May 11, 2018

SELL
$17.2 - $34.95 $142,760 - $290,085
-8,300 Reduced 97.65%
200 $0
Q4 2017

Jan 17, 2018

SELL
$12.65 - $19.0 $63,250 - $95,000
-5,000 Reduced 37.04%
8,500 $4,000
Q3 2017

Oct 17, 2017

BUY
$4.7 - $11.7 $63,450 - $157,950
13,500
13,500 $16,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.